相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes A Systematic Review and Meta-analysis
Sean L. Zheng et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices: An Application for Eliciting Patient Preferences for Diabetes Treatments.
Ellen M. Janssen et al.
VALUE IN HEALTH (2018)
Glycemic Targets: Standards of Medical Care in Diabetes-2018
DIABETES CARE (2018)
Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2018
DIABETES CARE (2018)
Patient preferences for diabetes treatment attributes and drug classes
Emuella M. Flood et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review
Tessa Kennedy-Martin et al.
PATIENT PREFERENCE AND ADHERENCE (2017)
The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study
Christian Bommer et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom
Lei Qin et al.
DIABETES THERAPY (2017)
Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey
Carol Mansfield et al.
DIABETES THERAPY (2017)
Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naive Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study
Lei Qin et al.
DIABETES THERAPY (2017)
Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom
Lei Qin et al.
DIABETES THERAPY (2017)
Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey
Carol Mansfield et al.
DIABETES THERAPY (2017)
Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naive Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study
Lei Qin et al.
DIABETES THERAPY (2017)
Characteristics Associated with the Choice of First Injectable Therapy Among US Patients With Type 2 Diabetes
Maria Yu et al.
CLINICAL THERAPEUTICS (2017)
Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
Louis S. Matza et al.
BMC HEALTH SERVICES RESEARCH (2017)
Discrete Choice Experiment Attribute Selection Using a Multinational Interview Study: Treatment Features Important to Patients with Type 2 Diabetes Mellitus
Anna Ryden et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2017)
A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes
A. Brett Hauber et al.
CURRENT MEDICAL RESEARCH AND OPINION (2016)
Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database
Andrew J. Farmer et al.
DIABETES CARE (2016)
Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes A Meta-analysis
Suetonia C. Palmer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The relative burden of diabetes complications on healthcare costs: The population-based CINECA-SID ARNO Diabetes Observatory
E. Pagano et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2016)
What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences
Axel Muehlbacher et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2016)
Change in Medical Spending Attributable to Diabetes: National Data From 1987 to 2011
Xiaohui Zhuo et al.
DIABETES CARE (2015)
Adherence to diabetes medication: a systematic review
I. Krass et al.
DIABETIC MEDICINE (2015)
Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naive type 2 diabetes patients in the UK
Heather L. Gelhorn et al.
PATIENT PREFERENCE AND ADHERENCE (2015)
Complex antithrombotic therapy: determinants of patient preference and impact on medication adherence
Neena S. Abraham et al.
PATIENT PREFERENCE AND ADHERENCE (2015)
A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus
A. Brett Hauber et al.
DIABETES THERAPY (2015)
A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus
A. Brett Hauber et al.
DIABETES THERAPY (2015)
Recognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatment
Davida F. Kruger et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2015)
Longitudinal Effects of Medication Nonadherence on Glycemic Control
Leonard E. Egede et al.
ANNALS OF PHARMACOTHERAPY (2014)
Patient Preferences for Noninsulin Diabetes Medications: A Systematic Review
Tanjala S. Purnell et al.
DIABETES CARE (2014)
Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry
S. Montilla et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2014)
Discrete Choice Experiments in Health Economics: A Review of the Literature
Michael D. Clark et al.
PHARMACOECONOMICS (2014)
Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study
Matthew Reaney et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2013)
Patient Preferences for the Treatment of Type 2 Diabetes: A Scoping Review
Susan M. Joy et al.
PHARMACOECONOMICS (2013)
Adherence to Therapies in Patients with Type 2 Diabetes
Luis-Emilio Garcia-Perez et al.
DIABETES THERAPY (2013)
Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study
Stephan Matthaei et al.
Diabetes Therapy (2012)
The Direct Economic Cost of Pharmacologically-Treated Diabetes in Italy-2006. The ARNO Observatory
G. Marchesini et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2011)
Conjoint Analysis Applications in Health - How are Studies being Designed and Reported? An Update on Current Practice in the Published Literature between 2005 and 2008
Deborah Marshall et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2010)
Validating the Body Uneasiness Test (BUT) in obese patients
G. Marano et al.
EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY (2007)
Impact of medication adherence on hospitalization risk and healthcare cost
MC Sokol et al.
MEDICAL CARE (2005)
Patient adherence improves glycemic control
MK Rhee et al.
DIABETES EDUCATOR (2005)
A systematic review of the associations between dose regimens and medication compliance
AJ Claxton et al.
CLINICAL THERAPEUTICS (2001)
分享论文
